Changes in physical activity around the time of major adverse cardiac events in patients with implantable cardioverter-defibrillators

被引:1
|
作者
Sommers, Thomas [1 ]
Yaeger, Amaryah [2 ]
Lin, David [2 ]
Marchlinski, Francis [2 ]
Nazarian, Saman [2 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, 55 Fruit St,Gray 730, Boston, MA 02114 USA
[2] Univ Penn, Perelman Sch Med, Cardiovasc Med Div, Sect Cardiac Electrophysiol, Philadelphia, PA USA
关键词
Physical activity; Major adverse cardiac events; Implantable cardioverter-defibrillator; Remote monitoring; Risk stratification; Biometrics; RESYNCHRONIZATION THERAPY; OUTCOMES;
D O I
10.1007/s10840-023-01524-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background With modern implantable cardioverter-defibrillators (ICDs), biometric measures including physical activity have become readily available to physicians. However, despite the increased availability, applications of these data to the clinical setting remain poorly studied. We sought to investigate whether changes in physical activity occur preceding and following cardiac events in patients with ICDs. Methods We reviewed the electronic medical records of patients with ICDs implanted for any indication in 2018 and 2019 in the University of Pennsylvania health system. Patients with ICDs that reported physical activity were included in the study only if they experienced major adverse cardiac event(s) (MACE) that were preceded by at least 6 months without MACE after device implantation. Results Seventy-four of the 827 charts reviewed met inclusion criteria. Baseline activity levels from 6 to 2 months prior to MACE were 2.18-2.21 h/day. In the month prior to MACE, average activity decreased significantly to 2.09 h/day, and subsequently decreased again during the calendar month in which MACE occurred to 1.96 h/day. The lowest average monthly activity levels occurred in the month after MACE, with incremental but non-significant recovery occurring over the subsequent 2 months. Conclusions In a cohort of ICD recipients, a significant decrease in physical activity was observed in the month preceding MACE. To our knowledge, this is the first study that observes time-dependent changes in activity in relation to MACE in a generalizable cohort of ICD recipients. ICD activity monitoring in patients at high risk for MACE may enhance patient care.
引用
收藏
页码:1919 / 1924
页数:6
相关论文
共 50 条
  • [41] Adding AI to the Toolkit for Patients With Implantable Cardioverter-Defibrillators
    Ramireddy, Archana
    Braunstein, Eric D.
    Chugh, Sumeet S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (01) : 56 - 57
  • [42] Effectiveness of implantable cardioverter-defibrillators in survivors of inhospital cardiac arrest
    Chan, Paul S.
    Krumholz, Harlan M.
    Spertus, John A.
    Curtis, Lesley H.
    Li, Yan
    Hammill, Bradley G.
    Nallamothu, Brahmajee K.
    AMERICAN HEART JOURNAL, 2015, 169 (06) : 870 - +
  • [43] Unmet needs for implantable cardioverter-defibrillators and cardiac resynchronization therapy
    Stavtseva, YVYuliya
    Villevalde, S. V.
    Kobalava, Z. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 155 - 155
  • [44] Primary prevention implantable cardioverter-defibrillators in transthyretin cardiac amyloidosis
    Donnellan, Eoin
    Wazni, Oussama M.
    Hanna, Mazen
    Saliba, Walid
    Jaber, Wael
    Kanj, Mohamed
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (11): : 1401 - 1403
  • [45] System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients
    Radbill, Andrew E.
    Triedman, John K.
    Berul, Charles I.
    Fynn-Thompson, Francis
    Atallah, Joseph
    Alexander, Mark E.
    Walsh, Edward P.
    Cecchin, Frank
    HEART RHYTHM, 2010, 7 (02) : 193 - 198
  • [46] Sex Differences in Physical Activity and Its Association With Cardiac Death and All-Cause Mortality in Patients With Implantable Cardioverter-Defibrillators
    Li, Xiaoyao
    Xue, Xiaodi
    Sun, Xuerong
    Zhao, Shuang
    Chen, Keping
    Hua, Wei
    Su, Yangang
    Yang, Jiefu
    Liang, Zhaoguang
    Xu, Wei
    Li, Zeyi
    Zhang, Shu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2020, 7
  • [47] Perioperative management of patients with pacemakers and implantable cardioverter-defibrillators
    Hollenbach, E.
    ANAESTHESIST, 2009, 58 (05): : 451 - 452
  • [48] Shocks as predictors of survival in patients with implantable cardioverter-defibrillators
    Pacifico, A
    Ferlic, LL
    Cedillo-Salazar, FR
    Nasir, N
    Doyle, TK
    Henry, PD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (01) : 204 - 210
  • [49] Implantable cardioverter-defibrillators in patients with left ventricular noncompaction
    Kobza, Richard
    Jenni, Rolf
    Erne, Paul
    Oechslin, Erwin
    Duru, Firat
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2008, 31 (04): : 461 - 467
  • [50] Longevity of lead systems in patients with implantable cardioverter-defibrillators
    Argenziano, M
    Spotnitz, HM
    Goldstein, DJ
    Weinberg, AD
    Dizon, JM
    Bigger, JT
    CIRCULATION, 2000, 102 (18) : 397 - 397